Innovating in biotechnology
We think high. We innovate in biotechnology. Together with our in-house expertise, Mecwins applies the latest advancements of Nanotechnology in the Diagnostic field with the mission of helping scientists and physicians to reach the unbelievable. The detection limit achieved with our technology is several order of magnitude better than that achieved in routine clinical practice.
Learn more about the science behind Mecwins technology
Mecwins uses its own technology based on single molecule digital counting to produce ultrahigh sensitive immunoassays for oncology, cardiovascular, inflammatory and infectious diseases.
We think high. Together with our in-house expertise, Mecwins applies the latest advancements of Nanotechnology in the Sensors field with the mission of helping scientists and physicians to reach the unbelievable
Mecwins team is comprised of experienced scientists and technicians. We aim to combine knowledge and expertise from different fields to provide innovative tools for research and analysis in life sciences. 50% of our team has a PhD degree.
The World Intellectual Property Organization (WIPO) protects our technology and our innovative method to detect biomolecules. Mecwins possesses exclusive licenses for several patents, since the technology thereby protected is usable in many applications, from microelectronics to biomedicine.
Since our establishment in 2008, we have forged strong relationships with several investors focus on the long-term value creation. They are the heart of our business and together with our scientific promoters (Dr. Javier Tamayo, Dr. Montserrat Calleja and Dr. Priscila Kosaka) help Mecwins to achieve its ambitious goals.
News and Events
Scientific developments never stop and neither can we. Explore the latest news and recent events in the world of Mecwins.
Discover the future of nanoscience
Mecwins' Rodrigo Calvo presents groundbreaking technology at NanoSpain2023 [...]
Mecwins installs state-of-the-art AVAC platform at Destina Genomica
Advancing the fight against Alzheimer's disease (CPP2021-008902, ALZHEIMER-PROmiR-SENSOR) From [...]
Mecwins receives new patent in USA and EU
Mecwins announced today that a new method for [...]